PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34951613-2	2022	We previously demonstrated that citrate-stabilized gold nanoparticles (Cit-AuNPs) interact with beta2-microglobulin (beta2m) preserving the protein native structure.	Citric Acid	32-39	beta-2-microglobulin	Homo sapiens	96-115	
28265615-0	2017	Citrate-stabilized gold nanoparticles hinder fibrillogenesis of a pathological variant of beta2-microglobulin.	Citric Acid	0-7	beta-2-microglobulin	Homo sapiens	90-109	
29737327-0	2018	Interference of citrate-stabilized gold nanoparticles with beta2-microglobulin oligomeric association.	Citric Acid	16-23	beta-2-microglobulin	Homo sapiens	59-78	
29737327-2	2018	NMR and QCMD experiments allowed us to establish that the interaction between citrate-stabilized gold nanoparticles and a paradigmatic amyloidogenic protein, beta2-microglobulin, is able to interfere with protein association into oligomers.	Citric Acid	78-85	beta-2-microglobulin	Homo sapiens	158-177	
29469914-0	2018	Citrate stabilized gold nanoparticles interfere with amyloid fibril formation: D76N and DeltaN6 beta2-microglobulin variants.	Citric Acid	0-7	beta-2-microglobulin	Homo sapiens	96-115	
29469914-4	2018	In particular citrate-coated gold nanoparticles (cit-AuNPs) were recently investigated with amyloidogenic protein beta2-microglobulin (beta2m).	Citric Acid	14-21	beta-2-microglobulin	Homo sapiens	114-133	
29469914-4	2018	In particular citrate-coated gold nanoparticles (cit-AuNPs) were recently investigated with amyloidogenic protein beta2-microglobulin (beta2m).	Citric Acid	14-21	beta-2-microglobulin	Homo sapiens	135-141	
25695203-5	2015	Here we present the first detailed structural characterization and molecular mechanics model of the interaction between a fibrillogenic protein, beta2-microglobulin, and a NP, 5 nm hydrophilic citrate-capped gold nanoparticles.	Citric Acid	193-200	beta-2-microglobulin	Homo sapiens	145-164	
25695203-8	2015	Simulations reproduce these findings and reveal instead the role of the citrate in destabilizing the lower pH protonated form of beta2-microglobulin.	Citric Acid	72-79	beta-2-microglobulin	Homo sapiens	129-148	
24367243-5	2013	RESULTS: In citrate OL-HDF pretreatment plasma levels of C-reactive protein and beta 2-microglobulin were significantly reduced; intra-treatment plasma acetate levels increased in the former technique and decreased in the latter.	Citric Acid	12-19	beta-2-microglobulin	Homo sapiens	80-100